3/23
08:04 am
goss
Gossamer Bio (GOSS) had its "neutral" rating reaffirmed by Cantor Fitzgerald.
Medium
Report
Gossamer Bio (GOSS) had its "neutral" rating reaffirmed by Cantor Fitzgerald.
3/23
05:55 am
goss
Rating for GOSS
Medium
Report
Rating for GOSS
3/23
05:11 am
goss
Gossamer Bio downgraded to Neutral from Overweight at Cantor Fitzgerald
Medium
Report
Gossamer Bio downgraded to Neutral from Overweight at Cantor Fitzgerald
3/20
04:44 pm
goss
Gossamer Bio downgraded to Neutral from Overweight at Cantor Fitzgerald
High
Report
Gossamer Bio downgraded to Neutral from Overweight at Cantor Fitzgerald
3/5
12:52 pm
goss
Rating for GOSS
Medium
Report
Rating for GOSS
3/5
12:52 pm
goss
Rating for GOSS
Medium
Report
Rating for GOSS
2/24
06:19 pm
goss
Gossamer Bio downgraded to Neutral from Buy at Goldman Sachs
Medium
Report
Gossamer Bio downgraded to Neutral from Buy at Goldman Sachs
2/24
06:19 pm
goss
Gossamer Bio downgraded to Neutral from Buy at Goldman Sachs
Medium
Report
Gossamer Bio downgraded to Neutral from Buy at Goldman Sachs
2/24
06:19 pm
goss
Gossamer Bio downgraded to Neutral from Buy at Goldman Sachs
Medium
Report
Gossamer Bio downgraded to Neutral from Buy at Goldman Sachs
2/24
08:48 am
goss
Rating for GOSS
Medium
Report
Rating for GOSS
2/24
08:48 am
goss
Rating for GOSS
Medium
Report
Rating for GOSS
2/24
08:42 am
goss
Gossamer Bio (NASDAQ:GOSS) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $1.00 price target on the stock.
Medium
Report
Gossamer Bio (NASDAQ:GOSS) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $1.00 price target on the stock.
2/24
08:42 am
goss
Gossamer Bio (NASDAQ:GOSS) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $1.00 price target on the stock.
Medium
Report
Gossamer Bio (NASDAQ:GOSS) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $1.00 price target on the stock.
2/24
08:22 am
goss
Rating for GOSS
Medium
Report
Rating for GOSS
2/24
08:22 am
goss
Rating for GOSS
Medium
Report
Rating for GOSS
2/24
08:11 am
goss
Rating for GOSS
Medium
Report
Rating for GOSS
2/24
07:19 am
goss
Gossamer Bio downgraded to Neutral from Outperform at Wedbush
Medium
Report
Gossamer Bio downgraded to Neutral from Outperform at Wedbush
2/24
07:19 am
goss
Gossamer Bio downgraded to Neutral from Outperform at Wedbush
Medium
Report
Gossamer Bio downgraded to Neutral from Outperform at Wedbush
2/24
07:01 am
goss
Gossamer Bio (NASDAQ:GOSS) was upgraded by analysts at Royal Bank Of Canada to an "outperform" rating.
Medium
Report
Gossamer Bio (NASDAQ:GOSS) was upgraded by analysts at Royal Bank Of Canada to an "outperform" rating.
2/24
07:01 am
goss
Gossamer Bio (NASDAQ:GOSS) was upgraded by analysts at Royal Bank Of Canada to an "outperform" rating.
Medium
Report
Gossamer Bio (NASDAQ:GOSS) was upgraded by analysts at Royal Bank Of Canada to an "outperform" rating.
2/24
06:03 am
goss
Gossamer Bio (NASDAQ:GOSS) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "underweight" rating.
Medium
Report
Gossamer Bio (NASDAQ:GOSS) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "underweight" rating.
2/24
05:29 am
goss
Gossamer Bio downgraded to Market Perform from Outperform at Leerink
Medium
Report
Gossamer Bio downgraded to Market Perform from Outperform at Leerink
2/24
04:53 am
goss
Gossamer Bio downgraded to Underweight from Overweight at Barclays
Medium
Report
Gossamer Bio downgraded to Underweight from Overweight at Barclays
2/24
04:53 am
goss
Gossamer Bio downgraded to Underweight from Overweight at Barclays
Medium
Report
Gossamer Bio downgraded to Underweight from Overweight at Barclays
2/24
04:01 am
goss
Gossamer Bio (NASDAQ:GOSS) was downgraded by analysts at Leerink Partners to a "market perform" rating.
Medium
Report
Gossamer Bio (NASDAQ:GOSS) was downgraded by analysts at Leerink Partners to a "market perform" rating.